FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2744763475> ?p ?o ?g. }

• W2744763475 endingPage "e0182411" @default.
• W2744763475 startingPage "e0182411" @default.
• W2744763475 abstract "Background Antibiotics are frequently used to treat wheezing children. Macrolides may be effective in treating bronchiolitis and asthma. Method We completed a prospective, double-blinded, randomized placebo-control trial of azithromycin among pre-school children (12 to 60 months of age) presenting to the emergency department with wheeze. Patients were randomized to receive either five days of azithromycin or placebo. Primary outcome was time to resolution of respiratory symptoms after treatment initiation. Secondary outcomes included the number of days children used a Short-Acting Beta-Agonists during the 21 day follow-up and time to disease exacerbation during the following six months (unscheduled health care visit or treatment with an oral corticosteroid for acute respiratory symptoms). Results Of the 300 wheezing children recruited, 222 and 169 were analyzed for the primary and secondary outcomes, respectively. The treatment groups had similar demographics and clinical parameters at baseline. Median time to resolution of respiratory symptoms was four days for both treatment arms (interquartile range (IQR) 3,6; p = 0.28). Median number of days of Short-Acting Beta-Agonist use among those who received azithromycin was four and a half days (IQR 2, 7) and five days (IQR 2, 9; p = 0.22) among those who received placebo. Participants who received azithromycin had a 0.91 hazard ratio for time to six-month exacerbation compared to placebo (95% CI 0.61, 1.36, p = 0.65). A pre-determined subgroup analysis showed no differences in outcomes for children with their first or repeat episode of wheezing. There was no significant difference in the proportion of participants experiencing an adverse event. Conclusion Azithromycin neither reduced duration of respiratory symptoms nor time to respiratory exacerbation in the following six months after treatment among wheezing preschool children presenting to an emergency department. There was no significant effect among children with either first-time or prior wheezing." @default.
• W2744763475 created "2017-08-17" @default.
• W2744763475 creator A5002378682 @default.
• W2744763475 creator A5024992458 @default.
• W2744763475 creator A5045182602 @default.
• W2744763475 creator A5048872472 @default.
• W2744763475 creator A5059092939 @default.
• W2744763475 creator A5060307614 @default.
• W2744763475 creator A5066330589 @default.
• W2744763475 creator A5072749068 @default.
• W2744763475 creator A5088991282 @default.
• W2744763475 date "2017-08-03" @default.
• W2744763475 modified "2023-10-17" @default.
• W2744763475 title "Treatment of preschool children presenting to the emergency department with wheeze with azithromycin: A placebo-controlled randomized trial" @default.
• W2744763475 cites W1516441032 @default.
• W2744763475 cites W1974143308 @default.
• W2744763475 cites W1977559696 @default.
• W2744763475 cites W1980111566 @default.
• W2744763475 cites W2006007763 @default.
• W2744763475 cites W2018680667 @default.
• W2744763475 cites W2044978081 @default.
• W2744763475 cites W2049438316 @default.
• W2744763475 cites W2054412029 @default.
• W2744763475 cites W2065755766 @default.
• W2744763475 cites W2068792844 @default.
• W2744763475 cites W2072619523 @default.
• W2744763475 cites W2084906213 @default.
• W2744763475 cites W2100213958 @default.
• W2744763475 cites W2116519763 @default.
• W2744763475 cites W2118319650 @default.
• W2744763475 cites W2141287869 @default.
• W2744763475 cites W2148377766 @default.
• W2744763475 cites W2152497270 @default.
• W2744763475 cites W2156304672 @default.
• W2744763475 cites W2161912768 @default.
• W2744763475 cites W2165014456 @default.
• W2744763475 cites W2165053145 @default.
• W2744763475 cites W2176892781 @default.
• W2744763475 cites W2202178402 @default.
• W2744763475 cites W2312397711 @default.
• W2744763475 cites W2315466988 @default.
• W2744763475 doi "https://doi.org/10.1371/journal.pone.0182411" @default.
• W2744763475 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5542589" @default.
• W2744763475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28771627" @default.
• W2744763475 hasPublicationYear "2017" @default.
• W2744763475 type Work @default.
• W2744763475 sameAs 2744763475 @default.
• W2744763475 citedByCount "35" @default.
• W2744763475 countsByYear W27447634752017 @default.
• W2744763475 countsByYear W27447634752018 @default.
• W2744763475 countsByYear W27447634752019 @default.
• W2744763475 countsByYear W27447634752020 @default.
• W2744763475 countsByYear W27447634752021 @default.
• W2744763475 countsByYear W27447634752022 @default.
• W2744763475 countsByYear W27447634752023 @default.
• W2744763475 crossrefType "journal-article" @default.
• W2744763475 hasAuthorship W2744763475A5002378682 @default.
• W2744763475 hasAuthorship W2744763475A5024992458 @default.
• W2744763475 hasAuthorship W2744763475A5045182602 @default.
• W2744763475 hasAuthorship W2744763475A5048872472 @default.
• W2744763475 hasAuthorship W2744763475A5059092939 @default.
• W2744763475 hasAuthorship W2744763475A5060307614 @default.
• W2744763475 hasAuthorship W2744763475A5066330589 @default.
• W2744763475 hasAuthorship W2744763475A5072749068 @default.
• W2744763475 hasAuthorship W2744763475A5088991282 @default.
• W2744763475 hasBestOaLocation W27447634751 @default.
• W2744763475 hasConcept C118552586 @default.
• W2744763475 hasConcept C119060515 @default.
• W2744763475 hasConcept C126322002 @default.
• W2744763475 hasConcept C142724271 @default.
• W2744763475 hasConcept C168563851 @default.
• W2744763475 hasConcept C187212893 @default.
• W2744763475 hasConcept C204787440 @default.
• W2744763475 hasConcept C27081682 @default.
• W2744763475 hasConcept C2776042228 @default.
• W2744763475 hasConcept C2777014857 @default.
• W2744763475 hasConcept C2778338976 @default.
• W2744763475 hasConcept C2778821649 @default.
• W2744763475 hasConcept C2778907293 @default.
• W2744763475 hasConcept C2780724011 @default.
• W2744763475 hasConcept C501593827 @default.
• W2744763475 hasConcept C534529494 @default.
• W2744763475 hasConcept C71924100 @default.
• W2744763475 hasConcept C86803240 @default.
• W2744763475 hasConcept C89423630 @default.
• W2744763475 hasConceptScore W2744763475C118552586 @default.
• W2744763475 hasConceptScore W2744763475C119060515 @default.
• W2744763475 hasConceptScore W2744763475C126322002 @default.
• W2744763475 hasConceptScore W2744763475C142724271 @default.
• W2744763475 hasConceptScore W2744763475C168563851 @default.
• W2744763475 hasConceptScore W2744763475C187212893 @default.
• W2744763475 hasConceptScore W2744763475C204787440 @default.
• W2744763475 hasConceptScore W2744763475C27081682 @default.
• W2744763475 hasConceptScore W2744763475C2776042228 @default.
• W2744763475 hasConceptScore W2744763475C2777014857 @default.
• W2744763475 hasConceptScore W2744763475C2778338976 @default.
• W2744763475 hasConceptScore W2744763475C2778821649 @default.
• W2744763475 hasConceptScore W2744763475C2778907293 @default.

• next